Days after Glenmark Pharmaceuticals launched its anti-viral drug to treat coronavirus patients, the company's shares surged 40 per cent to Rs 572.7 on Monday in the intra-day trade on the BSE.

Glenmark's shares rise up to 40% following launch of potential coronavirus drug

glenmark-pharmaceuticals

Glenmark Pharmaceuticals, News on Glenmark Pharmaceuticals, stories on Glenmark Pharmaceuticals, articles on Glenmark Pharmaceuticals, Glenmark Pharmaceuticals stories at Wion, Glenmark Pharmaceuticals news, Glenmark Pharmaceuticals latest news

glenmark pharmaceuticals

Glenmark's shares rise up to 40% following launch of potential coronavirus drug